How many institutions held ENTX - Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 in Q3 2026?

2 institutional investors reported ENTX - Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 for Q3 2026. Use the holders table for investor-level position and value details.

Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 (ENTX)

Q: What does CUSIP M40527109 represent in this 13F holders report?

CUSIP M40527109 is the security identifier for ENTX - Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 used to aggregate holder disclosures.

CUSIP: M40527109

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Ordinary Shares, par value of NIS 0.0000769
Total 13F shares: 47,329
Total 13F value: $137,727
Share change: +1
SEC-reported price per share: $2.96
Number of holders: 2
Value change: +$3
Number of buys: 1
Shares outstanding: 173,760,059

Security key

M40527109

Report period

Q3 2026

Institutions

Top holders

ENTX full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Entera Bio Ltd. SEC filings Entera Bio Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP M40527109

Previous quarter: Q1 2026

Recent filing periods:

Q3 2026 Q1 2026

Ownership snapshot

Top reported holders of ENTX - Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BIOTECHNOLOGY VALUE FUND L P

Disclosed value leader

BIOTECHNOLOGY VALUE FUND L P

Comparable rows

7/15

Latest evidence

07 Aug 2026

13D/G 13F 3/4/5 Lead comparable stake: 10% 8 rows are not safely comparable across share classes. 13D/G row: BIOTECHNOLOGY VALUE FUND L P Showing 1-6 of 15 holder rows.

Quick read

BIOTECHNOLOGY VALUE FUND L P leads the comparable SEC ownership view at 10%.

7 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BIOTECHNOLOGY VALUE FUND L P's linked filing trail.

Comparable ownership Top 5

BIOTECHNOLOGY VALUE FUND L P 10%

OPKO HEALTH, INC. 8.1%

TCG Crossover GP III, LLC 7.1%

Vivo Opportunity Fund Holdings, L.P. 6.9%

Longitude Capital Partners V, LLC 4.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BIOTECHNOLOGY VALUE FUND L P	13D/G BVF PARTNERS L P/IL 13D/G	10% Reported 13D/G · 28 Jul 2026	$28,593,701 17,225,121 shares	$0	28 Jul 2026
OPKO HEALTH, INC.	13D/G 13D/G	8.1% Reported 13D/G · 16 Mar 2025	$8,660,281 3,685,226 shares	$0	16 Mar 2025
TCG Crossover GP III, LLC	13D/G 13D/G	7.1% Reported 13D/G · 28 Jul 2026	$20,343,136 12,254,901 shares	$0	28 Jul 2026
Vivo Opportunity Fund Holdings, L.P.	13D/G Vivo Opportunity, LLC 13D/G	6.9% Reported 13D/G · 28 Jul 2026	$19,616,886 11,817,401 shares	$0	28 Jul 2026
Longitude Capital Partners V, LLC	13D/G 13D/G	4.6% Reported 13D/G · 28 Jul 2026	$13,019,609 7,843,138 shares	$0	28 Jul 2026
Seven Fleet Capital Management LP	13D/G 13F Company 13D/G 13F	4.1% Reported 13D/G · 28 Jul 2026	$11,709,471 7,053,898 shares	$0	28 Jul 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

47,329

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q3 2026 holders

Holder diff

-24

Investor	Q1 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend